Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| W81XWH-12-2-0012 | Other Grant/Funding Number | Department of Defense | |
| W81XWH-13-1-0259 | Other Grant/Funding Number | Department of Defense | |
| W81XWH-14-1-0462 | Other Grant/Funding Number | Department of Defense |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| United States Department of Defense | FED |
| Telemedicine & Advanced Technology Research Center | OTHER |
| Northern California Institute of Research and Education | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Traumatic brain injury (TBI) and post traumatic stress disorder (PTSD) are common combat related problems and may be associated with a greater risk of Alzheimer's disease (AD). The purpose of this study is to examine the possible connections between TBI and PTSD, and the signs and symptoms of AD on Veterans as they age.
The information collected will help to learn more about how these injuries may affect Veterans of the Vietnam War as they grow older, as well as Veterans of the current wars in Iraq and Afghanistan, who also have these types of combat related injuries.
The overall long-term goal of this project is to prevent AD, which affects almost 50% of the US population over 85 years of age, and is the most common cause of dementia. Clinical signs and symptoms of AD include cognitive impairments, especially memory and emotional disturbances. In order to accomplish this goal of prevention, a population at risk must be identified. Evidence suggests that both TBI and PTSD increase risk for cognitive decline, AD, and dementia.
TBI and PTSD are common problems resulting from military service. Thus far, there have been no prospective studies using imaging and biomarkers, which directly measure changes in the brain and AD pathology to study the effects of TBI and PTSD. This proposed study will provide novel data to test these hypotheses. The results will have major implications for identifying, subjects at increased risk for AD, a possible need for early detection of AD in military Veterans with histories of TBI and PTSD, and a possible need to employ prevention and treatment measures to avoid accelerated development of AD in US military Veterans. This study is a first step toward a larger, more comprehensive study of dementia risk factors in Veterans. The results will lead to a design and statistical powering of a prevention trial. Therefore, this project could be the first step toward the prevention of AD in Veterans, and in the general population.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Traumatic Brain Injury (TBI) | 65-100 Vietnam Veterans with Traumatic Brain Injury (TBI), but without PTSD, mild cognitive impairment (MCI)/dementia | ||
| Post Traumatic Stress Disorder (PTSD) | 65-100 Vietnam Veterans with PTSD, but without TBI, MCI/dementia | ||
| Controls | 65-100 Vietnam Veteran Controls without TBI or PTSD and comparable in age, gender, and education to the other cohorts | ||
| TBI w/ MCI | 65-100 Vietnam Veterans with TBI but without PTSD who meet the criteria for MCI but not dementia | ||
| PTSD w/ MCI | 65-100 Vietnam Veterans with PTSD but without TBI who meet the criteria for MCI but not dementia | ||
| Controls w/ MCI | 65-100 Vietnam Veteran Controls without TBI or PTSD who meet the criteria for MCI but not dementia, and are comparable in age, gender, and education to the other cohorts |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Rates of change in brain regions based on neuroimaging | Rates of change in brain regions based on neuroimaging (magnetic resonance imaging [MRI] and amyloid positron-emission tomography [PET]) to show that those with TBI and/or PTSD have increased evidence for AD compared to Veteran controls | 1 year |
| Rates of change in CSF amyloid beta and CSF tau/P tau levels based on biomarkers | Rates of change in CSF amyloid beta and CSF tau/P tau levels based on biomarkers such as cerebrospinal fluid (CSF) to show that those with TBI and/or PTSD have increased evidence for AD compared to Veteran controls | 1 year |
| Rates of change in neuropsychological measures of memory and general cognitive performance | Rates of change in neuropsychological measures of memory and general cognitive performance based on cognitive measures to show that those with TBI and/or PTSD have increased evidence for AD compared to Veteran controls | 1 Year |
| Measure | Description | Time Frame |
|---|---|---|
| Correlations within each group (TBI and PTSD) to assess whether baseline levels or rates of atrophy or cognitive decline are associated with severity of TBI or PTSD | 1 year | |
| Group differences in the patterns of amyloid deposition (from Florbetapir F 18) and brain atrophy |
Not provided
Participants will be classified as either controls, TBI, or PTSD. General Inclusion/Exclusion Criteria will apply to all groups, with specific criteria for each group as described below.
Inclusion Criteria:
General (applies to each cohort):
Specific Inclusion Criteria for Controls:
Specific Inclusion Criteria for TBI:
Subjects must have a documented history of moderate-severe non-penetrating TBI, which occurred during military service in Vietnam (identified from the Department of Defense or VA records);
TBI will be defined as:
Specific Inclusion Criteria for PTSD:
Exclusion Criteria:
General (applies to each cohort):
MCI/dementia;
History of psychosis or bipolar affective disorder;
History of alcohol or substance abuse/dependence within the past 5 years (by DSM-IV-TR criteria) or a prior prolonged history of abuse;
MRI-related exclusions: aneurysm clips, metal implants that are determined to be unsafe for MRI; and/or claustrophobia;
Contraindications for lumbar puncture, PET scan, or other procedures in this study;
Any major medical condition must be stable for at least 4 months prior to enrollment. These include but are not limited to clinically significant hepatic, renal, pulmonary, metabolic or endocrine disease, cancer, HIV infection and AIDS, as well as cardiovascular disease, including:
Seizure disorder or any systemic illness affecting brain function during the past 5 years will be exclusionary;
Clinical evidence of stroke;
Have a history of relevant severe drug allergy or hypersensitivity;
Subjects with current clinically significant unstable medical comorbidities, as indicated by history or physical exam, that pose a potential safety risk to the subject.
Specific Exclusion Criteria for Controls:
• Exclusionary criteria applied to TBI/PTSD (outlined below) will be applied to controls.
Specific Exclusion Criteria for TBI:
• Presence of PTSD by SCID-I for DSM-IV-TR criteria, or a CAPS score of >30 (Both current and/or a history of PTSD will be excluded).
Specific Exclusion Criteria for PTSD:
Not provided
Not provided
Vietnam Veterans
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael W. Weiner, MD | University of California, San Francisco | Study Director |
| Paul Aisen, MD | USC Alzheimer's Therapeutic Research Institute (ATRI) | Principal Investigator |
| Ronald Petersen, MD, PhD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Banner Sun Health Research Institute | Sun City | Arizona | 85351 | United States | ||
| University of California, Irvine |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 17476317 | Background | Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005 Jul;1(1):55-66. doi: 10.1016/j.jalz.2005.06.003. | |
| 20451868 | Background | Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M; Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May;6(3):202-11.e7. doi: 10.1016/j.jalz.2010.03.007. |
| Label | URL |
|---|---|
| Alzheimer's Disease Neuroimaging Initiative (ADNI) | View source |
Not provided
Not provided
| San Francisco Veterans Affairs Medical Center |
| FED |
| Alzheimer's Therapeutic Research Institute | OTHER |
Not provided
Not provided
Not provided
blood, urine, cerobrospinal fluid
Group differences may give insight into whether TBI or PTSD is associated with reduced brain reserve causing greater cognitive impairments as indicated by neuropsychological test performance.
| 1 year |
| Group differences in white matter integrity as assessed with Diffusion Tension Imaging (DTI) | Group differences in axonal damage as indicated by white matter integrity measured with DTI to determine if axonal injury resulting from TBI is associated with greater amyloid accumulation or whether brain regions with axonal damage have less amyloid accumulation due to disconnection and reduced brain activity. | 1 year |
| Rate of change of tau deposition as measured by 18F-AV-1451 | Rates of change in brain regions based on Tau PET neuroimaging to show that those with TBI and/or PTSD have increased evidence for AD compared to Veteran controls | 1 year |
| Irvine |
| California |
| 92697 |
| United States |
| University of California, San Diego | La Jolla | California | 92093 | United States |
| University of Southern California | Los Angeles | California | 90033 | United States |
| VA Palo Alto HSC / Stanford School of Medicine | Palo Alto | California | 94304 | United States |
| University of California, San Francisco | San Francisco | California | 94117 | United States |
| Georgetown University | Washington D.C. | District of Columbia | 20057 | United States |
| Howard University | Washington D.C. | District of Columbia | 20060 | United States |
| Wien Center for Clinical Research | Miami Beach | Florida | 33140 | United States |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | United States |
| Rush University Medical Center | Chicago | Illinois | 60612 | United States |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | United States |
| Cornell Medical Center | New York | New York | 10021 | United States |
| Columbia University | New York | New York | 10032 | United States |
| University of Rochester Medical Center | Rochester | New York | 14620 | United States |
| Duke University Medical Center | Durham | North Carolina | 27710 | United States |
| Roper St Francis Healthcare | Charleston | South Carolina | 29401 | United States |
| U of WA / VA Puget Sound Alzheimer's Disease Research Center | Seattle | Washington | 98108 | United States |
| University of Wisconsin | Madison | Wisconsin | 53705 | United States |
| 20083042 | Background | Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010 Jan;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6. |
| 19636049 | Background | Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb. |
| U.S. Department of Veterans Affairs | View source |
| Laboratory of Neuro Imaging (LONI) | View source |
| Alzheimer's Therapeutic Research Institute | View source |
| ID | Term |
|---|---|
| D000070642 | Brain Injuries, Traumatic |
| D013313 | Stress Disorders, Post-Traumatic |
| D000544 | Alzheimer Disease |
| D060825 | Cognitive Dysfunction |
| D003704 | Dementia |
| D003072 | Cognition Disorders |
| D020774 | Pick Disease of the Brain |
| ID | Term |
|---|---|
| D001930 | Brain Injuries |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D006259 | Craniocerebral Trauma |
| D020196 | Trauma, Nervous System |
| D014947 | Wounds and Injuries |
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D001523 | Mental Disorders |
| D024801 | Tauopathies |
| D019636 | Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D057180 | Frontotemporal Dementia |
| D057174 | Frontotemporal Lobar Degeneration |
Not provided
Not provided